Perioperative Tumour Marker Levels as Prognostic Factors for Surgical Treatment of Breast Cancer Liver Metastases
Language English Country Greece Media print
Document type Journal Article
PubMed
29848722
DOI
10.21873/anticanres.12640
PII: 38/6/3647
Knihovny.cz E-resources
- Keywords
- Breast cancer liver metastases, liver surgery, tumour markers,
- MeSH
- Survival Analysis MeSH
- CA-19-9 Antigen blood MeSH
- Antigens, Neoplasm blood MeSH
- Adult MeSH
- Carcinoembryonic Antigen blood MeSH
- Keratin-19 blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Biomarkers, Tumor blood MeSH
- Liver Neoplasms secondary surgery MeSH
- Breast Neoplasms pathology surgery MeSH
- Peptides blood MeSH
- Perioperative Period * MeSH
- Prognosis MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- CA-19-9 Antigen MeSH
- antigen CYFRA21.1 MeSH Browser
- Antigens, Neoplasm MeSH
- Carcinoembryonic Antigen MeSH
- Keratin-19 MeSH
- Biomarkers, Tumor MeSH
- Peptides MeSH
- tissue polypeptide specific antigen MeSH Browser
BACKGROUND/AIM: The results of surgical treatment of breast cancer liver metastases (BCLM) remain suboptimal. The search for perioperative prognostic factors could help determine high risk groups of patients. The aim of study was to evaluate the significance of tumour markers (TM) on long-term treatment results. PATIENTS AND METHODS: Liver surgery was carried out in 32 women for BCLM. The perioperative serum levels of CEA, CA19-9, TPA, TPS, CYFRA 21-1 and TK were determined. RESULTS: Preoperative levels of CA19-9 were significant for overall survival (OS)(p<0.05) and recurrence-free survival (RFS) (p<0.01). TPA, TPS and CYFRA 21-1 levels were significant for OS (p<0.05; p<0.04; p<0.05). Postoperative levels of CEA, TPS and CYFRA 21-1 were significant for RFS (p<0.04; p<0.01; p<0.02), while CA19-9 postoperative levels were significant for OS and RFS (p<0.03; p<0.01). CONCLUSION: Perioperative TM serum levels may represent prognostic indicators reflecting the results of surgical treatment of BCLM.
Department of Surgery University Hospital Faculty of Medicine Pilsen Czech Republic
Immunodiagnostic Department University Hospital Faculty of Medicine Pilsen Czech Republic
References provided by Crossref.org